文献速递冠心病

澳大利亚农村急性冠脉综合征管理:MORACS随机临床试验

Management of Acute Coronary Syndromes in Patients in Rural Australia: The MORACS Randomized Clinical Trial.
PubMed 文献 · JAMA Cardiol · 2022-01-01

该集群随机临床试验纳入澳大利亚29家无急诊专科医生的农村医院急诊科,比较常规诊疗与由三级医院远程支持的MORACS干预对ST段抬高型心肌梗死(STEMI)漏诊的影响。结果显示MORACS组STEMI漏诊比例显著降低(0% vs 35%,P<.001),且接受直接再灌注治疗的比例更高(100% vs 64%,P<.001);漏诊STEMI患者死亡率显著高于准确诊断者。

要点

  • MORACS远程诊断支持可消除农村医院STEMI漏诊(0% vs 35%)。
  • MORACS干预提高直接再灌注治疗率(100% vs 64%)。
  • 漏诊STEMI与显著增高的死亡风险相关(RR 13.2)。

核心结论

  • MORACS诊断支持服务降低了农村医院STEMI漏诊比例并提高了直接再灌注治疗率。
  • 准确诊断STEMI与较低死亡率相关。

研究设计与样本

  • 集群随机临床试验,纳入澳大利亚29家无急诊专科医生的农村医院急诊科,随机分为常规诊疗组与MORACS干预组。
  • 共纳入6249例疑似急性冠脉综合征患者,平均年龄63.6岁(SD 12.2),48%为女性;研究期间为2018年12月至2020年4月。

主要发现

  • 常规诊疗医院STEMI占疑似ACS急诊就诊的2.0%(77/7474),MORACS医院占1.3%(46/7474)。
  • STEMI漏诊在常规诊疗组为35%(27/77),MORACS组为0%(0/46),P<.001。
  • 符合条件患者接受直接再灌注治疗的比例:常规诊疗组64%(48/75),MORACS组100%(36/36),P<.001。
  • 12个月死亡率:常规诊疗组10.3%(8例),MORACS组6.5%(3例),相对风险0.64(95%CI 0.18-2.23)。
  • 漏诊STEMI患者死亡率为25.9%(7例),准确诊断者为2.0%(1例),相对风险13.2(95%CI 1.71-102.00,P=.001)。

关键数值与推荐

  • 疑似ACS症状触发自动通知三级医院 coronary care unit,远程审查心电图和床旁肌钙蛋白结果,并电话协助农村医院医生诊断和启动治疗。

临床怎么用

  • 在农村无急诊专科医生的医院,对疑似ACS患者应启动远程诊断支持以降低STEMI漏诊。
  • 远程支持可促进直接再灌注治疗的及时启动。

局限性

  • 12个月死亡率比较的置信区间较宽,需谨慎解读。
  • 研究仅纳入澳大利亚农村医院,外推性受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Treatment of ST-segment elevation myocardial infarction (STEMI) in rural settings involves thrombolysis followed by transfer to a percutaneous coronary intervention-capable hospital. The first step is accurate diagnosis via electrocardiography (ECG), but one-third of all STEMI incidents go unrecognized and hence untreated. OBJECTIVE: To reduce missed diagnoses of STEMI. DESIGN, SETTING, AND PARTICIPANTS: This cluster randomized clinical trial included 29 hospital emergency departments (EDs) in rural Australia with no emergency medicine specialists, which were randomized to usual care vs automatically triggered diagnostic support from the tertiary referral hospital (management of rural acute coronary syndromes [MORACS] intervention). Patients presenting with symptoms compatible with acute coronary syndromes (ACS) were eligible for inclusion. The study was conducted from December 2018 to April 2020. Data were analyzed in August 2021. INTERVENTION: Triage of a patient with symptoms compatible with ACS triggered an automated notification to the tertiary hospital coronary care unit. The ECG and point-of-care troponin results were reviewed remotely and a phone call was made to the treating physician in the rural hospital to assist with diagnosis and initiation of treatment. MAIN OUTCOMES AND MEASURES: The proportion of patients with missed STEMI diagnoses. RESULTS: A total of 6249 patients were included in the study (mean [SD] age, 63.6 [12.2] years; 48% female). Of 7474 ED presentations with suspected ACS, STEMI accounted for 77 (2.0%) in usual care hospitals and 46 (1.3%) in MORACS hospitals. Missed diagnosis of STEMI occurred in 27 of 77 presentations (35%) in usual care hospitals and 0 of 46 (0%) in MORACS hospitals (P < .001). Of eligible patients, 48 of 75 (64%) in the usual care group and 36 of 36 (100%) in the MORACS group received primary reperfusion (P < .001). In the usual care group, 12-month mortality was 10.3% (n = 8) vs 6.5% (n = 3) in the MORACS group (relative risk, 0.64; 95% CI, 0.18-2.23). Patients with missed STEMI diagnoses had a mortality of 25.9% (n = 7) compared with 2.0% (n = 1) for those with accurately diagnosed STEMI (relative risk, 13.2; 95% CI, 1.71-102.00; P = .001). Overall, there were 6 patients who did not have STEMI as a final diagnosis; 5 had takotsubo cardiomyopathy and 1 had pericarditis. There was no difference between groups in the rate of alternative final diagnosis. CONCLUSION AND RELEVANCE: The findings indicate that MORACS diagnostic support service reduced the proportion of missed STEMI and improved the rates of primary reperfusion therapy. Accurate diagnosis of STEMI was associated with lower mortality. TRIAL REGISTRATION: anzctr.org.au Identifier: ACTRN12619000533190.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Dee F, Savage L, Leitch JW, et al. Management of Acute Coronary Syndromes in Patients in Rural Australia: The MORACS Randomized Clinical Trial. JAMA Cardiol. 2022. PMID: 35612860. doi:10.1001/jamacardio.2022.1188

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。